What is emphysematous cystitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Emphysematous Cystitis?

Emphysematous cystitis is a rare, severe urinary tract infection characterized by gas formation within the bladder wall and lumen, caused by gas-producing bacteria, most commonly Escherichia coli and Klebsiella species 1.

Pathophysiology and Causative Organisms

This condition results from infection with gas-producing pathogens that generate carbon dioxide and nitrogen within the bladder tissue 1. The most frequently implicated organisms are:

  • Escherichia coli (most common)
  • Klebsiella pneumoniae 2
  • Proteus mirabilis 3
  • Enterococcus faecalis 2

Infections may be polymicrobial, which portends a worse prognosis 3.

Risk Factors and Predisposing Conditions

The condition predominantly affects patients with specific predisposing factors 2:

  • Diabetes mellitus (especially uncontrolled) - the most common risk factor
  • Immunosuppression (including chronic corticosteroid therapy) 2
  • Neurogenic bladder and urinary tract dysfunction 2, 4
  • Chronic urinary tract infections 5
  • Advanced age, particularly in women 4
  • Indwelling urethral catheters 4
  • Bladder outlet obstruction 4

A critical pitfall: emphysematous cystitis can present in patients without traditional risk factors, requiring high clinical suspicion even in seemingly low-risk individuals 6.

Clinical Presentation

The presentation varies dramatically from asymptomatic incidental findings to life-threatening septic shock 5:

Typical symptoms include:

  • Dysuria
  • Hematuria (including gross hematuria) 6
  • Suprapubic/lower abdominal pain 6
  • Fever 4
  • Decreased urine output 2

Atypical presentations:

  • Hypoglycemia rather than hyperglycemia in diabetic patients - a dangerous presentation that can mislead clinicians 3
  • Altered mental status 3
  • Asymptomatic (discovered incidentally on imaging) 5

Severe presentations may include:

  • Septic shock requiring vasopressors 3
  • Multiorgan dysfunction (cardiovascular, renal, neurological, hematological) 2
  • Prostration and vomiting 2

Diagnosis

CT imaging is the gold standard for diagnosis 2. Computed tomography demonstrates:

  • Gas within the bladder wall (pathognomonic finding)
  • Gas within the bladder lumen
  • Gas tracking into retropubic and extraperitoneal spaces (in severe cases) 2
  • Contrast-enhanced studies can exclude bladder rupture 2

Plain radiography may show gas but CT provides superior detail for diagnosis and management planning 2.

Complications

Emphysematous cystitis can lead to life-threatening complications:

  • Bladder necrosis and perforation 2, 4
  • Peritonitis/pelviperitonitis 4
  • Septic shock 2, 6
  • Emphysematous pyelonephritis 4
  • Pleural effusion (associated with worse prognosis) 3
  • Death despite maximal medical therapy 3

Prognostic indicators of poor outcome:

  • Polymicrobial bacteremia 3
  • Presence of pleural effusion 3
  • Multiorgan failure 3
  • Inability to perform surgical intervention when indicated 3

Management Approach

Treatment requires early broad-spectrum antibiotics targeting common gram-negative pathogens (E. coli, Klebsiella), with therapy duration of 7-14 days adjusted based on clinical response 1.

The management algorithm includes:

  1. Immediate resuscitation and supportive care for septic patients
  2. Broad-spectrum intravenous antibiotics targeting E. coli and Klebsiella species 1
  3. Urinary bladder drainage (catheterization) 5
  4. Early urology consultation - essential before multiorgan failure develops 3
  5. Tailoring antibiotics based on culture and susceptibility results 2
  6. Consideration of percutaneous drainage or surgical intervention in severe cases, particularly for emphysematous pyelonephritis where drainage shows lower mortality 1

Most cases respond to conservative medical management with antibiotics and bladder drainage, avoiding surgical intervention 2. However, severe cases may require cystectomy, and when surgical intervention is not possible, mortality remains high despite aggressive medical management 3.

Key Clinical Pearls

  • Suspect emphysematous cystitis in diabetic patients presenting with hypoglycemia and septic shock - this atypical presentation can be fatal 3
  • Asymptomatic cases still warrant prompt treatment despite lack of symptoms, given the potential for rapid deterioration 5
  • Multidisciplinary management is crucial - involve urology, infectious disease, and critical care early 2
  • Serial examinations and close monitoring are essential even in stable-appearing patients 6
  • The presence of structural urinary tract abnormalities increases risk of extensive disease 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.